Riskpilot← Back to searchSign inGet full accessHemsö Medicinaren AB
ABActiveOrg 5568222359Hästholmsvägen 28Rental and operating of own or leased real estate · NACE 6820Est. 20100 employees
Revenue 2024
SEK 103,7M
+2% vs 2023
EBITDA margin
51.2%
+5% vs 2023
Equity ratio
15.2%
Financial strength
Net profit 2024
SEK -31,6M
-790% vs 2023
| Revenue | SEK 103,7M | +2% |
| EBITDA | SEK 53,1M | +5% |
| Net profit | SEK -31,6M | -790% |
| Total assets | SEK 1,3B | -3% |
| Equity | SEK 194,7M | -14% |
| Employees | 0 | — |
Legal name
Hemsö Medicinaren AB
Org number
5568222359
Legal form
Aktiebolag
NACE code
6820 · Rental and operating of own or leased real estate
Founded
29 oktober 2010
Share capital
SEK 50 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas två i förening av Cedergren, Nina Gunilla Källén, Claes Rutger Olof Wilborg, Sven Mats Algot
Company purpose
Bolaget skall äga och förvalta fastigheter och därmed förenlig verksamhet.
Address
Hästholmsvägen 28
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 89 529 | 88 232 | 88 396 | 101 490 | 103 710 |
| Staff expenses | — | — | — | — | — |
| EBITDA | 38 071 | 41 272 | 37 701 | 50 386 | 53 114 |
| Depreciation & amort. | — | — | — | — | — |
| EBIT | 38 071 | 41 272 | 37 701 | 50 386 | 53 114 |
| Net financials | −11 888 | −11 826 | −16 927 | −39 368 | −59 443 |
| Profit before tax | 3 499 | 7 185 | 9 485 | 11 019 | −27 701 |
| Tax | −3 170 | −3 916 | −2 818 | −6 441 | −3 869 |
| Net profit | 329 | 3 269 | 6 667 | 4 578 | −31 570 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 728 649 | 854 437 | 980 762 | 1 313 492 | 1 277 460 |
| Equity | 81 775 | 85 044 | 291 711 | 226 290 | 194 720 |
| Long-term debt | 585 000 | 585 000 | 415 000 | 1 000 000 | 1 000 000 |
| Short-term debt | 30 470 | 149 073 | 235 913 | 45 574 | 37 243 |
| Total debt | 615 470 | 734 073 | 650 913 | 1 045 574 | 1 037 243 |
EBITDA margin
51.2%
This company
15.8%
Market median
+224% vs market
20202024
Equity ratio
15.2%
This company
38.2%
Market median
-60% vs market
20202024
Return on equity
-16.2%
This company
18.4%
Market median
-188% vs market
20202024
Net profit margin
-30.4%
This company
8.1%
Market median
-475% vs market
20202024
Asset turnover
0.08×
This company
1.12×
Market median
-93% vs market
20202024
Debt / equity
5.56×
This company
0.62×
Market median
-797% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
SM External Signatory | External Signatory | 2022 |
NG External Signatory | External Signatory | 2020 |
CE Chief Auditor | Chief Auditor | 2022 |
| Former (3) | ||
NG External Signatory | External Signatory | 2020 – 2022 |
SM Chief Auditor | Chief Auditor | 2020 – 2022 |
LR External Signatory | External Signatory | 2020 – 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2020 | |
| Deputy Board Member | 2020 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 0001 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
TREDJE AP-FONDEN
Hemsö Medicinaren AB Board members of Hemsö Medicinaren AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Nils Gustav Björkman | External Signatory | 0 companies |
| Sven Magnus Fredmer | Chief Auditor | 0 companies |
| Sven Mats Algot Wilborg | External Signatory | 0 companies |
| Nina Gunilla Cedergren | External Signatory | 0 companies |
| Leif Rikard Nyhrén | External Signatory | 0 companies |
| Carl Emil Peter Dahllöf | Chief Auditor | 0 companies |
| Nils Javier Styf | Board of Directors | 0 companies |
| Claes Rutger Olof Källén | Deputy Board Member | 0 companies |